clinicalomicsprowebdirectory
News
Topics
Informatics
Molecular Dx
New Products
Oncology
Patient Care
Precision Medicine
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Multimedia
eBooks
Inside Precision Medicine Live
Podcasts
Virtual Event
Webinars
On Demand Webinars
Subscribe
Create a Free Account
Log In
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Gut Microbiome May Affect Immunotherapy Effect
artificial intelligence
Cardiovascular Disease Onset Can Be Predicted Using AI Tools
Genetic Disease Testing
Chance Most “Pathogenic” Variants Will Actually Cause Disease Is Low
Coronavirus
New, Inexpensive Test Detects SARS-CoV-2 Genome Without PCR
drug discovery
Targeted Antisense Drug Shows Promise Against ALS
Topics
Informatics
Molecular Dx
New Products
Oncology
Patient Care
Precision Medicine
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Multimedia
All
eBooks
Inside Precision Medicine Live
Podcasts
Virtual Event
Webinars
Cancer Testing
Delivering Cancer Care Equity via In-House NGS Testing
On Demand Webinars
Digital Solutions to Alleviate NASH Clinical Trial Challenges
Cancer Testing
Podcast Series: Comprehensive Genomic Profiling
Virtual Event
Digital Insights to Tumor Biology
Subscribe
Create a Free Account
Log In
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Home
Precision Medicine
Business
Business
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
News Briefs
Lloyd Sanders Named New CEO of Epic Sciences
March 26, 2019
Business
10 Leading Immuno-Oncology Startups
March 25, 2019
Business
Mammoth Competition: Feng Zhang, Partners Launch CRISPR Dx Company
March 22, 2019
Business
Viome, Helomics Partner on Personalized Ovarian Cancer Treatments
March 21, 2019
Business
Ambry and My Gene Counsel Team Up on Tests to Confirm...
March 19, 2019
Business
UK Commits £45M Toward Capacity Expansion at EMBL-EBI
March 15, 2019
Business
Myriad Genetics Gets Medicare Coverage for myPath Melanoma Test
March 14, 2019
Business
Lucence, Stanford Researcher to Develop AI Algorithms for Liver Cancer Treatment
March 14, 2019
Business
BGI Genomics to Commercialize Natera’s Signatera Assay in China
March 13, 2019
Business
Biocartis, BMS to Partner on CDx for mCRC Immunotherapy Combination
March 12, 2019
Load more
Featured
Gut Microbiome May Affect Immunotherapy Effect
January 26, 2022
Cardiovascular Disease Onset Can Be Predicted Using AI Tools
January 25, 2022
New, Inexpensive Test Detects SARS-CoV-2 Genome Without PCR
January 25, 2022
Targeted Antisense Drug Shows Promise Against ALS
January 25, 2022
New Products
View All
Digital PCR Leverages Microfluidic Array Tech
October 26, 2021
Simplified PCR Cleanup and Plasmid Prep
October 19, 2021
Pharmacogenetics Home Collection Test Kit
October 19, 2021
Load more
![Myriad Genetics has received a final local coverage determination for its myPath Melanoma test from the Medicare Administrative Contractor Palmetto GBA MolDx. [Myriad Genetics]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/03/2189-324x160.jpeg "Myriad Genetics Gets Medicare Coverage for myPath Melanoma Test")
![Lucence Diagnostics will partner with a Stanford University researcher to develop AI algorithms designed to improve the diagnosis and treatment of liver cancer. [Lucence Diagnostics]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/03/2187-324x160.jpeg "Lucence, Stanford Researcher to Develop AI Algorithms for Liver Cancer Treatment")
![Biocartis will partner with Bristol-Myers Squibb (BMS) to develop a companion diagnostic for the pharma giant’s immuno-oncology therapies based on the Belgian molecular diagnostics developer’s Idylla MSI test. [Biocartis]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/03/2185-324x160.jpeg "Biocartis, BMS to Partner on CDx for mCRC Immunotherapy Combination")
